​

SELLAS Life Sciences Group (SLS) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

SLS Stock Forecast

SELLAS Life Sciences Group (SLS) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $2.80, with a high of $3.20 and a low of $2.40. This represents a 69.70% increase from the last price of $1.65.

High: $3.2 Avg: $2.8 Low: $2.4 Last Closed Price: $1.65

SLS Stock Rating

SELLAS Life Sciences Group stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 5 Strong Sell Sell Hold Buy Strong Buy

SLS Price Target Upside V Benchmarks

TypeNameUpside
StockSELLAS Life Sciences Group69.70%
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.65$1.65$1.65
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 2512---3
May, 2512---3
Apr, 2512---3
Mar, 2512---3
Feb, 2512---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 15, 2022Industrial Alliance Securities$3.20$0.89259.55%93.94%
Jun 28, 2022Cantor Fitzgerald$2.40$0.93158.06%45.45%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 15, 2022Alliance Global PartnersBuyBuyhold
Jun 28, 2022Cantor FitzgeraldOverweightOverweighthold

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.34$-2.10$-1.34$-0.05----
Avg Forecast$-1.34$-2.10$-1.01$-0.54$-0.47$-0.48$-0.09$1.11
High Forecast$-1.34$-2.10$-1.01$-0.54$-0.47$-0.38$0.25$1.11
Low Forecast$-1.34$-2.10$-1.01$-0.54$-0.47$-0.56$-0.42$1.11
Surprise %--32.67%-90.74%----

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.60M$1.00M------
Avg Forecast$5.07M$1.00M$13.00M-$31.98M$32.85M$89.10M$158.71M
High Forecast$5.07M$1.00M$13.00M-$31.98M$32.85M$89.10M$158.71M
Low Forecast$5.07M$1.00M$13.00M-$31.98M$32.85M$89.10M$158.71M
Surprise %50.00%-------

Net Income Forecast

$-60M $-41M $-22M $-3M $16M $35M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-20.70M$-40.65M$-37.34M$-30.88M----
Avg Forecast$-37.15M$-58.26M$-27.96M$-14.91M$-13.06M$-13.15M$-5.21M$30.83M
High Forecast$-37.15M$-58.26M$-27.96M$-14.91M$-13.06M$-10.68M$6.94M$30.83M
Low Forecast$-37.15M$-58.26M$-27.96M$-14.91M$-13.06M$-15.62M$-11.67M$30.83M
Surprise %-44.29%-30.23%33.54%107.16%----

SLS Forecast FAQ

Is SELLAS Life Sciences Group stock a buy?

SELLAS Life Sciences Group stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that SELLAS Life Sciences Group is a favorable investment for most analysts.

What is SELLAS Life Sciences Group's price target?

SELLAS Life Sciences Group's price target, set by 5 Wall Street analysts, averages $2.8 over the next 12 months. The price target range spans from $2.4 at the low end to $3.2 at the high end, suggesting a potential 69.70% change from the previous closing price of $1.65.

How does SELLAS Life Sciences Group stock forecast compare to its benchmarks?

SELLAS Life Sciences Group's stock forecast shows a 69.70% upside, outperforming the average forecast for the healthcare stocks sector (23.68%) and outperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for SELLAS Life Sciences Group over the past three months?

  • June 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is SELLAS Life Sciences Group’s EPS forecast?

SELLAS Life Sciences Group's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.47, marking a 840.00% increase from the reported $-0.05 in 2024. Estimates for the following years are $-0.48 in 2026, $-0.09 in 2027, and $1.11 in 2028.

What is SELLAS Life Sciences Group’s revenue forecast?

SELLAS Life Sciences Group's average annual revenue forecast for its fiscal year ending in December 2025 is $31.98M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $32.85M, followed by $89.1M for 2027, and $158.71M for 2028.

What is SELLAS Life Sciences Group’s net income forecast?

SELLAS Life Sciences Group's net income forecast for the fiscal year ending in December 2025 stands at $-13.055M, representing a -57.72% decrease from the reported $-30.881M in 2024. Projections indicate $-13.15M in 2026, $-5.206M in 2027, and $30.83M in 2028.